Human Antithrombin III (AT3) AssayMax ELISA Kit (WHO Standard Calibrated Positive and Low Controls Included)

Name: Human Antithrombin III (AT3) AssayMax ELISA Kit (WHO Standard Calibrated Positive and Low Controls Included)
Brand: AssayMax&trade; ELISA Kits
SKU: EA3301-8
Availability: InStock

$500.00

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Catalog Number. EA3301-8 Categories: ELISA Kits, Kits, Sandwich ELISA Tags: Antithrombin III, AT3, ATIII, PRO0309, Serpin C1 Brand: AssayMax™ ELISA Kits

Additional information

Format	Sandwich ELISA
Entrez Gene	462
Components	Biotinylated Human Antithrombin III Antibody, Chromogen Substrate (1x), Human Antithrombin III Microplate, Human Antithrombin III Standard, Low Control, MIX Diluent Concentrate (10x), Positive Control, Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)
TIme	4 hours
Sensitivity	0.65 ng/ml
Range	3.125 – 200 ng/ml; 0.005 – 0.3 mIU/ml
Samples Type	CSF, Milk, Plasma, Saliva, Serum, Urine
Associated Disease	Cardiovascular
Species	Human
UniProt	P01008
Storage	Refer to component labels for details
Plex	1
Usage	For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications

"* Vitalievna SE (2021) Indicators of Endothelial dysfunction and factors hemostasis in patients with stable and unstable atherosclerotic plaques. Scientific Research Institute of therapy and preventive medicine. Thesis.
"* Stryukova EV (2021) Indicator of endothelial dysfunction and factors hemostasis in patients iwht stable and unstable atherosclerotic plates. Federal Research Center Institue of Cytology and Genetics of the Siberian Branch Russian Academy of Sciences. Dissertation.
"* Kondo A et al. (2021) Measuring serum prothrombin in patients treated with warfarin or direct oral anticoagulants. Clin Chim Acta. 523:224-230.
"* Sikora M et al. (2020) Cystathionine beta?synthase defciency: diferent changes in proteomes of thrombosis?resistant Cbs?/? mice and thrombosis?prone CBS?/? humans.
"* Premkumar M et al. (2020) Heparin-like Effect Associated With Risk of Bleeding, Sepsis, and Death in Patients With Severe Alcohol-Associated Hepatitis. Clin Gastroenterol Hepatol. 18(2):486-495.e3.
"* Ragino YI et al. (2019) Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis. BMC Res Notes. 12(1):336.
"* Premkumar M et al. (2019) Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute on chronic liver failure: An observational cohort study. Liver Int. 39(4):694-704
"* Nnachi OC et al. (2019) Antithrombin Levels in Adults with Ischaemic Stroke seen at the University of Benin Teaching Hospital, Benin City. J. Res. Basic Clin. Sciences. 1(3).
"* Chan KC et al. (2019) Astaxanthin attenuated thrombotic risk factors in type 2 diabetic patients. Journal of Functional Foods. 53:22-27
"* Banerjee A et al. (2018) Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma. J Trauma Acute Care Surg. 84(6): 929-938.
"* Selmeczi A et al. (2017) Antithrombin Debrecen (p. Leu205Pro)?Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency. Thromb Res. 158:1-7
"* Schochl H et al. (2017) Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis. Critical Care. 21(1):51
"* Nair JK et al. (2017) Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc?siRNA conjugates. Nucleic Acids Res. 45(19):10969-10977. doi: 10.1093/nar/gkx818
"* Sehgal A et al. (2015) An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia. Nature Medicine 21(5):492-497
"* Saleh AAW et al. (2014) Markers of Inflammation and Thrombophilia in Psoriasis. Med. J. Cairo Univ. 82(1):127-131
"* Cubedo J et al. (2013) High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction. Thromb Haemost. 110(6):1121-34.
"* Yang MH et al. (2012) Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease. J Proteomics. 75(12):3617-29.
"* Andersen RF et al. (2012) Plasma and urine proteomic profiles in childhood idiopathic nephrotic syndrome. Proteomics Clin Appl. 6(7-8):382-93
"* Verrills NM et al. (2011) Identification of Novel Diagnostic Biomarkers for Asthma and Chronic Obstructive Pulmonary Disease. AJRCCM. doi:10.1164/rccm.201010-1623OC.
"* Oberbach A et al. (2011) Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes. J Proteome Res. 10(10):4769-88

Human Antithrombin III (AT3) AssayMax ELISA Kit (WHO Standard Calibrated Positive and Low Controls Included)

Additional information

Documentation

Publications

Related products

Human Antithrombin III (AT3) Antibody (Biotin Conjugate)

Bovine Antithrombin III (AT III) Antibody (Biotin Conjugate)

Human Antithrombin III (AT3) AssayLite Antibody (FITC Conjugate)

Human Antithrombin III (AT3) Antibody (Biotin Conjugate)